Khan S - Search Results

1

MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.

Khan S, Wall D, Curran C, Newell J, Kerin MJ, Dwyer RM. Khan S, et al. BMC Cancer. 2015 May 2;15:345. doi: 10.1186/s12885-015-1374-y. BMC Cancer. 2015. PMID: 25934412 Free PMC article.

2

Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.

Potter SM, Dwyer RM, Hartmann MC, Khan S, Boyle MP, Curran CE, Kerin MJ. Potter SM, et al. Among authors: khan s. Breast Cancer Res Treat. 2012 Jan;131(2):401-11. doi: 10.1007/s10549-011-1410-9. Epub 2011 Feb 23. Breast Cancer Res Treat. 2012. PMID: 21344235

3

miR-379 regulates cyclin B1 expression and is decreased in breast cancer.

Khan S, Brougham CL, Ryan J, Sahrudin A, O'Neill G, Wall D, Curran C, Newell J, Kerin MJ, Dwyer RM. Khan S, et al. PLoS One. 2013 Jul 10;8(7):e68753. doi: 10.1371/journal.pone.0068753. Print 2013. PLoS One. 2013. PMID: 23874748 Free PMC article.

4

Isolation of secreted microRNAs (miRNAs) from cell-conditioned media.

Glynn CL, Khan S, Kerin MJ, Dwyer RM. Glynn CL, et al. Among authors: khan s. Microrna. 2013;2(1):14-9. doi: 10.2174/2211536611302010003. Microrna. 2013. PMID: 25070711

5

Screening of exosomal microRNAs from colorectal cancer cells.

Clancy C, Khan S, Glynn CL, Holian E, Dockery P, Lalor P, Brown JA, Joyce MR, Kerin MJ, Dwyer RM. Clancy C, et al. Among authors: khan s. Cancer Biomark. 2016;17(4):427-435. doi: 10.3233/CBM-160659. Cancer Biomark. 2016. PMID: 27802194

6

Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).

Martin FT, Dwyer RM, Kelly J, Khan S, Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, O'Brien T, Kerin MJ. Martin FT, et al. Among authors: khan s. Breast Cancer Res Treat. 2010 Nov;124(2):317-26. doi: 10.1007/s10549-010-0734-1. Epub 2010 Jan 20. Breast Cancer Res Treat. 2010. PMID: 20087650

7

Advances in mesenchymal stem cell-mediated gene therapy for cancer.

Dwyer RM, Khan S, Barry FP, O'Brien T, Kerin MJ. Dwyer RM, et al. Among authors: khan s. Stem Cell Res Ther. 2010 Aug 9;1(3):25. doi: 10.1186/scrt25. Stem Cell Res Ther. 2010. PMID: 20699014 Free PMC article. Review.

8

Oncological Risk in Autologous Stem Cell Donation for Novel Tissue-Engineering Approaches to Postmastectomy Breast Regeneration.

O'Halloran N, Khan S, Gilligan K, Dwyer R, Kerin M, Lowery A. O'Halloran N, et al. Among authors: khan s. Breast Cancer (Auckl). 2019 Sep 19;13:1178223419864896. doi: 10.1177/1178223419864896. eCollection 2019. Breast Cancer (Auckl). 2019. PMID: 31555047 Free PMC article.

9

Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer.

Moloney BM, Gilligan KE, Joyce DP, O'Neill CP, O'Brien KP, Khan S, Glynn CL, Waldron RM, Maguire CM, Holian E, Naughton E, Elhadi M, Grealish AB, Malone C, McDermott E, Dockery P, Ritter T, Prina-Mello A, Kerin MJ, Dwyer RM. Moloney BM, et al. Among authors: khan s. Cells. 2020 Jan 7;9(1):141. doi: 10.3390/cells9010141. Cells. 2020. PMID: 31936142 Free PMC article.

10

Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.

O'Brien KP, Khan S, Gilligan KE, Zafar H, Lalor P, Glynn C, O'Flatharta C, Ingoldsby H, Dockery P, De Bhulbh A, Schweber JR, St John K, Leahy M, Murphy JM, Gallagher WM, O'Brien T, Kerin MJ, Dwyer RM. O'Brien KP, et al. Among authors: khan s. Oncogene. 2018 Apr;37(16):2137-2149. doi: 10.1038/s41388-017-0116-9. Epub 2018 Jan 25. Oncogene. 2018. PMID: 29367765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17,718 results

Search Page